105
Views
4
CrossRef citations to date
0
Altmetric
Original Research

In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease

, , , , , , , , & show all
Pages 2915-2921 | Published online: 11 Sep 2018

Figures & data

Figure 1 The efficacy of cephalosporins determined by BacTiter-Glo Assay.

Notes: Effect of drugs on Borrelia cell viability was studied with drugs (cefoxitin, cefamandole, cefuroxime, and cefapirin) on CA8 strain. The control has no drug. The results represent mean ± SD.
Figure 1 The efficacy of cephalosporins determined by BacTiter-Glo Assay.

Table 1 MIC and MBC values (in µM) of the tested compounds on bacterial strains CA8, JLB31, and NP40

Table 2 Therapeutic effectiveness of tested compounds in Borrelia burgdorferi-infected C3H mice

Table 3 Predicted docking scores of cephalosporins with Borrelia burgdorferi SecA-PBP and OspE

Figure 2 Spatial arrangement of the in silico tested cephalosporins with secA translocase PBP of Borrelia burgdorferi: (A) cefamandole, (B) cefapirin, (C) cefoxitin, and (D) cefuroxime.

Note: The amino acid sequence of secA-PBP (B. burgdorferi B31) was retrieved from the Uniprot KB (Gene BB_0718) with a GenBank gene accession number of AE000783 (translation AAC67056.2.).
Abbreviation: PBP, penicillin-binding protein.
Figure 2 Spatial arrangement of the in silico tested cephalosporins with secA translocase PBP of Borrelia burgdorferi: (A) cefamandole, (B) cefapirin, (C) cefoxitin, and (D) cefuroxime.

Table 4 Interaction of tested cephalosporins with Borrelia burgdorferi SecA-penicillin-binding protein (SecA-PBP)